Amnion-Derived Cells Help Wound Healing
Author Information
Author(s): Xing Liyu, Franz Michael G., Marcelo Cynthia L., Smith Charlotte A., Marshall Vivienne S., Robson Martin C.
Primary Institution: University of Michigan
Hypothesis
Can amnion-derived multipotent progenitor cells (AMPs) improve laparotomy wound healing and reduce complications?
Conclusion
AMP cell therapy reduces the incidence of laparotomy wound failure by accelerating the recovery of wound-breaking strength.
Supporting Evidence
- AMP cells were viable in laparotomy wounds for at least 28 days.
- Laparotomy wound-breaking strength was increased by postoperative day 7 following AMP therapy.
- AMP therapy reduced the incidence of hernia formation and the size of hernia defects.
- Histology suggested stimulated wound fibroplasia and angiogenesis.
Takeaway
Scientists found that special cells from amniotic tissue can help wounds heal faster and prevent complications like hernias.
Methodology
Rats were treated with amnion-derived cells before laparotomy, and wound healing was assessed over 28 days.
Limitations
The study was conducted on rats, which may not fully represent human responses.
Participant Demographics
Sprague-Dawley rats weighing 450 to 500 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website